# XBiotech Inc.: filings

XBIT · Nasdaq · CIK 1626878 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xbit.md) · [Financials](/companies/xbit/financials.md) · [Filings](/companies/xbit/filings.md) · [Insiders](/companies/xbit/insiders.md)

## Reports and events: 134 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 127, 8-K 58, 10-Q 35, 3 26, SC 13G/A 22, 4/A 16, SC 13G 14, 10-K 11, DEF 14A 11, CORRESP 10, DEFA14A 9, 10-K/A 8, UPLOAD 8, 424B5 5, SC TO-I/A 5, 10-Q/A 4, ARS 4, SCHEDULE 13G/A 4, 3/A 3, 8-K/A 3, S-1/A 3, S-8 3, EFFECT 2, FWP 2, SC TO-I 2, 424B4 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, DRS 1, S-1 1, S-3 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-02 | 11:13 ET | [DEF 14A](/filings/0001171843-26-006362.md) | Proxy statement, period 2026-11-24 | 0001171843-26-006362 |
| 2026-08-13 | 11:26 ET | [10-Q](/filings/0001171843-26-005492.md) | Quarterly report, period 2026-06-30 | 0001171843-26-005492 |
| 2026-05-14 | 14:43 ET | [10-Q](/filings/0001171843-26-003419.md) | Quarterly report, period 2026-03-31 | 0001171843-26-003419 |
| 2026-04-29 | 13:02 ET | [10-K/A](/filings/0001171843-26-002814.md) | Annual report, amended, period 2025-12-31 | 0001171843-26-002814 |
| 2026-03-13 | 14:33 ET | [10-K](/filings/0001171843-26-001561.md) | Annual report, period 2025-12-31 | 0001171843-26-001561 |
| 2025-12-09 | 09:00 ET | [8-K](/filings/0001171843-25-007836.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-007836 |
| 2025-11-12 | 11:45 ET | [10-Q](/filings/0001171843-25-007233.md) | Quarterly report, period 2025-09-30 | 0001171843-25-007233 |
| 2025-10-15 | 12:54 ET | [8-K/A](/filings/0001171843-25-006441.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-006441 |
| 2025-10-03 | 11:15 ET | [8-K](/filings/0001171843-25-006266.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-006266 |
| 2025-09-02 | 13:10 ET | [8-K](/filings/0001171843-25-005673.md) | 5.07 Shareholder vote results | 0001171843-25-005673 |
| 2025-08-13 | 14:49 ET | [10-Q](/filings/0001171843-25-005368.md) | Quarterly report, period 2025-06-30 | 0001171843-25-005368 |
| 2025-07-07 | 17:23 ET | [DEF 14A](/filings/0001193125-25-156276.md) | Proxy statement, period 2025-08-29 | 0001193125-25-156276 |
| 2025-06-24 | 17:06 ET | [8-K](/filings/0001171843-25-004066.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-004066 |
| 2025-05-14 | 15:55 ET | [10-Q](/filings/0001171843-25-003178.md) | Quarterly report, period 2025-03-31 | 0001171843-25-003178 |
| 2025-04-29 | 15:59 ET | [10-K/A](/filings/0001171843-25-002595.md) | Annual report, amended, period 2024-12-31 | 0001171843-25-002595 |
| 2025-04-07 | 16:50 ET | [8-K](/filings/0001171843-25-002067.md) | 3.01 Delisting notice | 0001171843-25-002067 |
| 2025-04-01 | 18:43 ET | [8-K](/filings/0001171843-25-001876.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-001876 |
| 2025-03-18 | 15:36 ET | [10-K](/filings/0001171843-25-001527.md) | Annual report, period 2024-12-31 | 0001171843-25-001527 |
| 2024-12-31 | 15:22 ET | [8-K](/filings/0001171843-24-007128.md) | 5.02 Departure or appointment of officers or directors | 0001171843-24-007128 |
| 2024-11-13 | 15:12 ET | [10-Q](/filings/0001171843-24-006336.md) | Quarterly report, period 2024-09-30 | 0001171843-24-006336 |
| 2024-08-12 | 14:38 ET | [10-Q](/filings/0001171843-24-004689.md) | Quarterly report, period 2024-06-30 | 0001171843-24-004689 |
| 2024-06-20 | 12:57 ET | [8-K](/filings/0001171843-24-003541.md) | 5.07 Shareholder vote results | 0001171843-24-003541 |
| 2024-05-10 | 11:27 ET | [10-Q](/filings/0001171843-24-002746.md) | Quarterly report, period 2024-03-31 | 0001171843-24-002746 |
| 2024-05-01 | 16:44 ET | [DEF 14A](/filings/0001193125-24-127578.md) | Proxy statement, period 2024-06-20 | 0001193125-24-127578 |
| 2024-05-01 | 15:32 ET | [10-K/A](/filings/0001193125-24-127331.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-127331 |
| 2024-04-24 | 09:57 ET | [10-K/A](/filings/0001193125-24-108802.md) | Annual report, amended, period 2023-12-31 | 0001193125-24-108802 |
| 2024-03-15 | 15:31 ET | [10-K](/filings/0001171843-24-001382.md) | Annual report, period 2023-12-31 | 0001171843-24-001382 |
| 2024-01-04 | 09:00 ET | [8-K](/filings/0001171843-24-000056.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-000056 |
| 2023-11-09 | 14:41 ET | [10-Q](/filings/0001171843-23-006944.md) | Quarterly report, period 2023-09-30 | 0001171843-23-006944 |
| 2023-08-11 | 11:18 ET | [10-Q](/filings/0001171843-23-005261.md) | Quarterly report, period 2023-06-30 | 0001171843-23-005261 |
| 2023-06-23 | 15:03 ET | [8-K](/filings/0001171843-23-004095.md) | 5.07 Shareholder vote results | 0001171843-23-004095 |
| 2023-05-10 | 15:41 ET | [10-Q](/filings/0001171843-23-003144.md) | Quarterly report, period 2023-03-31 | 0001171843-23-003144 |
| 2023-04-28 | 12:23 ET | [DEF 14A](/filings/0001193125-23-125528.md) | Proxy statement, period 2023-06-23 | 0001193125-23-125528 |
| 2023-03-15 | 16:58 ET | [10-K](/filings/0001171843-23-001705.md) | Annual report, period 2022-12-31 | 0001171843-23-001705 |
| 2023-02-15 | 19:47 ET | [8-K](/filings/0001193125-23-039510.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-039510 |
| 2022-11-09 | 15:26 ET | [10-Q](/filings/0001171843-22-007285.md) | Quarterly report, period 2022-09-30 | 0001171843-22-007285 |
| 2022-08-10 | 17:50 ET | [10-Q](/filings/0001171843-22-005546.md) | Quarterly report, period 2022-06-30 | 0001171843-22-005546 |
| 2022-06-29 | 11:47 ET | [8-K](/filings/0001171843-22-004610.md) | 5.07 Shareholder vote results | 0001171843-22-004610 |
| 2022-05-13 | 15:17 ET | [DEF 14A](/filings/0001193125-22-149975.md) | Proxy statement, period 2022-06-22 | 0001193125-22-149975 |
| 2022-05-13 | 15:01 ET | [8-K](/filings/0001171843-22-003680.md) | 4.01 Change of auditor | 0001171843-22-003680 |
| 2022-05-10 | 15:54 ET | [10-Q](/filings/0001171843-22-003510.md) | Quarterly report, period 2022-03-31 | 0001171843-22-003510 |
| 2022-03-15 | 17:01 ET | [10-K](/filings/0001171843-22-001904.md) | Annual report, period 2021-12-31 | 0001171843-22-001904 |
| 2022-02-02 | 16:15 ET | [8-K](/filings/0001171843-22-000711.md) | 1.01 Entry into a material agreement | 0001171843-22-000711 |
| 2021-11-09 | 12:53 ET | [10-Q](/filings/0001171843-21-007731.md) | Quarterly report, period 2021-09-30 | 0001171843-21-007731 |
| 2021-08-09 | 16:10 ET | [10-Q](/filings/0001171843-21-005700.md) | Quarterly report, period 2021-06-30 | 0001171843-21-005700 |
| 2021-07-06 | 17:08 ET | [8-K](/filings/0001171843-21-004741.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-21-004741 |
| 2021-05-10 | 17:15 ET | [10-Q](/filings/0001171843-21-003353.md) | Quarterly report, period 2021-03-31 | 0001171843-21-003353 |
| 2021-04-29 | 18:12 ET | [DEF 14A](/filings/0001171843-21-002901.md) | Proxy statement, period 2021-06-22 | 0001171843-21-002901 |
| 2021-03-16 | 16:28 ET | [10-K](/filings/0001171843-21-001828.md) | Annual report, period 2020-12-31 | 0001171843-21-001828 |
| 2020-11-09 | 17:28 ET | [10-Q](/filings/0001171843-20-007826.md) | Quarterly report, period 2020-09-30 | 0001171843-20-007826 |

Page 1 of 3. [Older](/companies/xbit/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 09:40 ET. No prices; not investment advice.